A Randomized Controlled Trial Comparing Daily Oral Iron Administration to Every Alternate Day Iron Administration in the Treatment of Iron Deficiency Anemia in Pediatric Patients.

5240248

Iron Deficiency Anemia (IDA) is a prevalent global health issue affecting a significant proportion of the population, including children. While daily oral iron supplementation is a common approach to treat IDA, concerns regarding side effects and compliance have led to exploration of alternative dosing schedules, such as every-other-day. This study aims to investigate the efficacy and safety of daily versus every other day oral iron supplementation in the management of IDA in pediatric patients.

2024-09-01

2024-11-01

2025-02-01

Not yet recruiting

Early phase I

100

Inclusion Criteria: * Confirmed Iron Deficiency Anemia * Pediatric patients (1-18 years of age) without regard of gender, race, ethnicity nor language. * Able and willing to take oral iron (tablet or liquid). Exclusion Criteria: * Pregnant or lactating patients * Known allergies or intolerance to oral iron formulations * Concomitant chronic medical conditions affecting iron metabolism * Short gut syndrome * Celiac disease * Inflammatory bowel disease * Cancer * Chronic kidney disease * Blood transfusions in the past 3 months * IV iron administration in the past 3 months * Oral iron supplementation in the past 2 weeks

{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}

2024-08-13